A comparative study of efficacy and safety of topical travoprost 0.004% versus latanoprost 0.005% in the treatment of primary open angle glaucoma at a tertiary care hospital
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2017, Vol 6, Issue 2
Abstract
Introduction Glaucoma, “silent thief of sight” is a chronic, progressive optic neuropathy leading to optic nerve damage and visual field loss. Lowering intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG) is beneficial in reducing the risk for visual field loss in the long term. Various prostaglandin analogues have demonstrated consistent superiority over other therapies in terms of IOP reduction, however superiority amongst them remains inconclusive. Objectives To compare efficacy and safety of topical travoprost 0.004% versus latanoprost 0.005% in reducing intraocular pressure in patients with POAG. Materials and methods 60 newly diagnosed patients of POAG who fulfilled the inclusion /exclusion criteria were randomised into two groups of 30 each to receive either travoprost or latanoprost once daily in the evening. Efficacy was measured in terms of reduction in IOP monitored at 4, 8 and 12 weeks from baseline. Safety was assessed by monitoring treatment emergent adverse drug reactions. Results Both travoprost and latanoprost effectively reduced IOP when compared to baseline. Mean IOP reduction from baseline to week 12 was 9.08 ± 1.93 mmHg (p<0.001), 7.96 ± 1.11 mmHg, (p<0.001) in travoprost and latanoprost groups respectively. There was significant reduction in IOP with travoprost when compared to latanoprost (8.86 ± 2.07 vs 7.71 ± 0.92, p=0.0003) at the end of 8 weeks and the same trend continued even at 12 weeks (9.08 ± 1.93 mmHg vs 7.96 ± 1.11 mmHg, p< 0.0002). Adverse drug reactions (ADR) were comparable in both the groups with conjunctival hyperaemia (21.6%) being the most common ADR. Conclusion Travoprost was found to be more efficacious in reducing IOP as early as 8 weeks as compared to latanoprost. There was an additional 1.12 mmHg reduction in IOP at the end of 12 weeks in comparison to latanoprost and it was well tolerated. Hence travoprost could be a favourable option for the treatment of primary open angle glaucoma.
Authors and Affiliations
C R Jayanthi
Keywords
Related Articles
- EP ID EP412930
- DOI -
- Views 100
- Downloads 0
Opinion and suggestions of undergraduate medical students on current teaching methods in pharmacology - A questionnaire based study
Background Pharmacology, like any other branch of medicine, is progressing by leaps and bounds. It is generally agreed that reviewing the teaching program at regular intervals, and modifications in the methodologies of i...
Anti-ulcer activity on cold stress induced ulcerative rats with column chromatographically isolated Ceiba pentandra flavonoids
This study evaluated the anti-ulcer activity of the ethanolic extract of Ceiba pentandra leaves on experimentally- induced gastric ulcer in rats. Animals were pre-treated with varied doses of the extract and reference dr...
Effects of Vitamin D on Blood Pressure: Vitamin D act as Anti Hypertensive agent
Aim The purpose of this study to rule out the role of vitamin D in hypertensive patients. Methodology Total 100 hypertensive patients were selected with same age and same disease criteria, they were divided in to two g...
A review of orphan drugs and rare diseases
The World Health Organization defines orphan diseases, as all pathological conditions, affecting 0.65-1 out of every 1000 inhabitants. They are usually not studied for their path physiology or for newer therapeutic optio...
A study on evaluation of hypothyroidism associated with pregnancy women
Maternal hypothyroidism may place the mother at an increased risk of adverse obstetrical outcomes. Untreated hypothyroidism is associated with increased risk for pre-eclampsia, low birth weight, placental abruption, mi...